This is a protocol for a randomized controlled trial testing a telehealth-delivered diabetes prevention program for individuals with traumatic brain injury.
Contemporary Clinical Trials Communications · 7 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a protocol for a randomized controlled trial testing a telehealth-delivered diabetes prevention program for individuals with traumatic brain injury.
This paper outlines the protocol for a randomized controlled trial (RCT) evaluating a telehealth-delivered diabetes prevention program (tGLB-TBI) for individuals with traumatic brain injury (TBI). The intervention is a modified, evidence-based Diabetes Prevention Program delivered via telehealth to address obesity and diabetes risk post-TBI, which are common and problematic sequelae. Primary and secondary outcomes, including weight, HbA1c, lipids, blood pressure, and quality of life, will be collected at baseline, 3, 6, and 12 months via local labs and telephonic interviews. Analyses will use linear mixed effects models to compare changes over time between groups. The protocol emphasizes broadening access to the program.